Hall Shannon received 1,774 derivative securities of MESA Laboratories on Sept. 9, bringing the resulting derivative securities holding to 1,774. For investors, the transaction represents about 100.0% of Hall Shannon’s resulting derivative securities position, identifying the full size of the holding created by the award.
Key Highlights
- Hall Shannon held 1,774 derivative securities after the transaction.
- The award represented about 100.0% of the resulting derivative securities holding.
- The transaction occurred on Sept. 9, 2026, under code A.
Hall Shannon was awarded 1,774 derivative securities of MESA Laboratories (NASDAQ: MLAB) on Sept. 9, 2026. Following the transaction, Hall Shannon owned 1,774 derivative securities of MESA Laboratories.
Award and Resulting Derivative Securities Position
Hall Shannon is a director of MESA Laboratories. The transaction was identified with code A. The post-transaction position stood at 1,774 derivative securities. The awarded amount represented about 100.0% of Hall Shannon’s resulting derivative securities holding in MESA Laboratories. Its recorded date was Sept. 9, 2026, and the resulting holding matched the number of securities awarded.
FAQs
Q: What did Hall Shannon receive from MESA Laboratories?
A: Hall Shannon received 1,774 derivative securities of MESA Laboratories on Sept. 9, 2026. The filing identified the transaction with SEC transaction code A.
Q: What was Hall Shannon’s resulting MESA Laboratories holding?
A: Hall Shannon held 1,774 derivative securities after the transaction. The filing states that the awarded amount matched the resulting derivative securities position.
Q: What percentage of Hall Shannon’s holding did the award represent?
A: The transaction represented about 100.0% of Hall Shannon’s resulting derivative securities holding in MESA Laboratories. The filing reported this percentage for the resulting holding after the transaction.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.